(Q37065216)

English

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences

scientific article published on March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences (English)

1 reference

Europe PubMed Central

18 August 2017

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

author name string

Christophe Legendre

1

1 reference

Europe PubMed Central

18 August 2017

Manuel Pascual

2

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

1 March 2008

1 reference

Europe PubMed Central

18 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

18 August 2017

46

1 reference

Europe PubMed Central

18 August 2017

5

1 reference

Europe PubMed Central

18 August 2017

732-740

1 reference

Europe PubMed Central

18 August 2017

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Infection in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Properties of CD4(+) T cells in human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Comparative Serial Virologic and Serologic Studies of Symptomatic and Subclinical Congenitally and Natally Acquired Cytomegalovirus Infections

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor‐Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

The dynamics of human cytomegalovirus replication in vivo

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

1 reference

https://api.crossref.org/works/10.1086%2F527397

21 January 2018

Identifiers

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37065216&oldid=2126692526"